PepGen shifts focus to PGN-EDODM1 for Myotonic Dystrophy Type 1 after discontinuing PGN-EDO51 for Duchenne Muscular Dystrophy ...

Baxter updated its full-year 2025 guidance, expecting total sales growth of 4% to 5% on a reported basis, incorporating approximately $320 million of anticipated MSA revenues from Vantive and a 50 ...

The Tennessee Titans have reached the midpoint of a miserable, not good and just plain ugly season with a chance to rest.

Value-based oncology care requires balancing rapid innovation with operational sustainability, equitable access, and ...

Let’s dig into the relative performance of Neogen (NASDAQ:NEOG) and its peers as we unravel the now-completed Q3 medical ...

Looking back on medical devices & supplies - diversified stocks’ Q3 earnings, we examine this quarter’s best and worst ...

But behind the spas’ allure, the evaluation found that clinics nationwide varied widely in their offerings and claims; only 2 ...

IVTherapyTrend and #hydrationtherapy, and #wellnessdrip all point toward intravenous infusions of fluids, vitamins, minerals and other compounds, in what' ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it will showcase 46 abstracts, ...

Discover the most competitive auto loan rates available in 2025, understand how to qualify and choose the best lender for your financing needs Written By Written by Staff Senior Editor, Buy Side ...

Higher early fluid resuscitation rates in acute pancreatitis are associated with an increased risk for systemic inflammatory ...

Prescription automation improves medication access by streamlining prior authorizations and reducing delays in patient treatment.